Vehicle of SJP-0035 Ophthalmic solution

DRUG2 trials

Sponsors

Senju Pharmaceutical Co., Ltd.

Conditions

Corneal Epithelial Disorders

Phase 2

Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders

CompletedNCT02104388

Senju Pharmaceutical Co., Ltd.Corneal Epithelial Disorders

Start: 2014-04-08End: 2015-08-04Updated: 2021-03-29

Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders

CompletedNCT02929823

Senju Pharmaceutical Co., Ltd.Corneal Epithelial Disorders

Start: 2016-09-30End: 2017-05-03Updated: 2021-04-13